GTF Milk Cardiovascular and Liver Health
- A healthy blood glucose level ensures healthy functioning of cardiovascular system.
- Patients with Type 2 diabetes have 2-5 times higher risk of myocardial infarction and 2-3 times higher risk of stroke compared to those without diabetes (Nathan, 1993).
- Reduction of 1% of HbA1c reduces the risk of microvascular complications, for example, risk of amputation can be reduced by 37% (Stratton et al., 2000).
- Triglycerides (TG), a kind of lipid that is normally converted from food, is stored in body and used as energy.
- However, high TG liked to several health complications including affecting of cardiovascular and liver health. One of the examples of the complications is Non-alcoholic fatty Liver Disease (NAFLD).
- Studies shown that chromium able to regulate TG level, and improves HDL level, hence able to enhance cardiovascular health (Huang et al., 2018). Besides that, chromium also helps to reduce atherosclerosis (Mao. 2006).
- Supplementation of chromium prevents insulin resistance associated NAFLD through the suppression of inflammation, improving lipid metabolism and reducing hepatic triglycerides (Chen et al., 2010)

(Sources: Chen et al., 2009)
- Chromium also serves as preventive towards cholestasis-induced hepatic damage by enhancing antioxidative capacity especially on BDL-induced hepatic oxidative stress. (Chen et al., 2009)
Reference:
- Chen, W.Y., Chen, C.J., Liu, C.H. and Mao, F.C., 2010. Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice. Biochemical and biophysical research communications, 397(3), pp.459-464.
- Chen, W.Y., Chen, C.J., Liao, J.W. and Mao, F.C., 2009. Chromium attenuates hepatic damage in a rat model of chronic cholestasis. Life Sciences, 84(17-18), pp.606-614.
- Mao, F.C. (2006). Super Discovery “6 in 1” – Regulating Blood Glucose, Insulin, Blood Lipid, Cholesterol, Leptin and Interleukin-6. Press Conference of the 16th Asian Agricultural Society Biannual Meeting, Taichung.
- Nathan, D.M., 1993. Long-term complications of diabetes mellitus. New England Journal of Medicine, 328(23), pp.1676-1685.